Charles Shyng Selected Research

Disease Progression

1/2018	Recent progress and considerations for AAV gene therapies targeting the central nervous system.
1/2017	Widespread Expression of a Membrane-Tethered Version of the Soluble Lysosomal Enzyme Palmitoyl Protein Thioesterase-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Charles Shyng Research Topics

Disease

3	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 01/2017 - 09/2014
2	Disease Progression 01/2018 - 01/2017
2	Lysosomal Storage Diseases (Lysosomal Storage Disease) 10/2014 - 09/2014
2	Gliosis 10/2014 - 09/2014
1	Angelman Syndrome (Syndrome, Angelman) 10/2021
1	Neurodevelopmental Disorders 01/2018
1	Atrophy 09/2014
1	Alzheimer Disease (Alzheimer's Disease) 09/2014
1	Neuroinflammatory Diseases 09/2014
1	Traumatic Brain Injuries (Traumatic Brain Injury) 09/2014

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2017 - 09/2014
2	EnzymesIBA 01/2017 - 10/2014
1	Protein Isoforms (Isoforms)IBA 10/2021
1	palmitoyl-protein thioesteraseIBA 01/2017
1	HydrolasesIBA 01/2017
1	VimentinIBA 10/2014
1	Kainic Acid (Kainate)IBA 09/2014
1	CytokinesIBA 09/2014
1	Lysergic Acid Diethylamide (LSD)IBA 09/2014
1	2- (4- (4- methyl- 6- phenylpyridazin- 3- yl)piperazin- 1- yl)pyrimidineIBA 09/2014

Therapy/Procedure

2	Therapeutics 01/2018 - 01/2017